Skip to main content

Pulmonary Complications of Solid Organ Transplantation

  • Chapter
  • First Online:
Pulmonary Complications of Non-Pulmonary Pediatric Disorders

Abstract

Solid organ transplantation (SOT), such as liver, kidney, intestinal, or multi-visceral transplant, is a complex undertaking, requiring consideration of appropriate procedural timing, the surgical approach, as well as multidisciplinary posttransplant care. Immunosuppression to prevent organ rejection is a pillar of postoperative care following transplantation, and this increases risk of opportunistic infections. Because of their exposure to the external environment, the lungs are particularly prone to such infectious complications following non-pulmonary SOT. Noninfectious pulmonary complications following SOT are also possible. These may be secondary to the primary reason for the SOT, to surgical complications accompanying transplantation, or to drug toxicity. In this chapter we will discuss these pulmonary complications of non-pulmonary solid organ transplant.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Feltracco P, Carollo C, Barbieri S, Pattenuzzo T, Ori C. Early respiratory complications after liver transplantation. World J Gastroenterol. 2013;19(48):9271–81.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Mack CL, Mills JM, Whitington PF, Alonso EM. Pulmonary complications following liver transplantation in pediatric patients. Pediatr Transplant. 2000;4(1):39–44.

    Article  CAS  PubMed  Google Scholar 

  3. Huddleston CB, Richey SR. Heart-lung transplantation. J Thorac Dis. 2014;6(8):1150–8.

    PubMed  PubMed Central  Google Scholar 

  4. Aguirre VJ, Sinha P, Zimmet A, Lee GA, Kwa L, Rosenfeldt F. Phrenic nerve injury during cardiac surgery: mechanisms, management and prevention. Heart Lung Circ. 2013;22(11):895–902.

    Article  PubMed  Google Scholar 

  5. De Gaspari A, Feltracco P, Ceravola E, Lee GA, Lachlan K, Rosenfeldt F. Pulmonary complications in patients receiving a solid-organ transplant. Curr Opin Crit Care. 2014;20(4):411–9.

    Article  Google Scholar 

  6. Yazdani M, Park E, Udayasankar U. Postsurgical diaphragmatic herniation: a rare delayed complication of pediatric intra-abdominal surgery. J Pediatr Surg. 2016;51(2):333–5.

    Article  PubMed  Google Scholar 

  7. Kirnap M, Akdur A, Ozcay F, Soy E, Coskun M, Moray G, et al. Diaphragmatic hernia after pediatric liver transplant. Exp Clin Transplant. 2015;13(5):471–4.

    PubMed  Google Scholar 

  8. Letourneau AR, Issa NC, Baden LR. Pneumonia in the immunocompromised host. Curr Opin Pulm Med. 2014;20(3):272–9.

    Article  PubMed  Google Scholar 

  9. Siniscalchi A, Aurini L, Benini B, Gamberini L, Nava S, Viale P, et al. Ventilator associated pneumonia following liver transplantation: etiology, risk factors and outcome. World J Transplant. 2016;6(2):389–95.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Garutti I, Sanz J, Olmedilla L, Tranche I, Vilchez A, Fernandez-Quero L, et al. Extravascular lung water and pulmonary vascular permeability index measured at the end of surgery are independent predictors of prolonged mechanical ventilation in patients undergoing liver transplantation. Anesth Analg. 2015;121(3):736–45.

    Article  PubMed  Google Scholar 

  11. Steinbach WJ. Invasive aspergillosis in pediatric patients. Curr Med Res Opin. 2010;26(7):1779–87.

    Article  CAS  PubMed  Google Scholar 

  12. Miceli MH, Maertens J. Role of non-culture based tests, with an emphasis on galactomannan testing for the diagnosis of invasive aspergillosis. Semin Respir Crit Care Med. 2015;36(5):650–61.

    Article  PubMed  Google Scholar 

  13. Kremery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect. 2002;50(4):243–60.

    Article  Google Scholar 

  14. Vazquez JA, Micelli MH, Alangaden G. Invasive fungal infections in transplant recipients. Ther Adv Infect Dis. 2013;1(3):85–105.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Chiou C, Groll A. Pediatric infectious diseases: the requisites in pediatrics. 1st ed. Philadelphia: Elsevier; 2008.

    Google Scholar 

  16. Tamm M, Traenkle P, Grill B, Soler M, Bollinger CT, Dalquen P, et al. Pulmonary cytomegalovirus infection in immunocompromised patients. Chest. 2001;119(3):838–43.

    Google Scholar 

  17. Ho M. Advances in understanding cytomegalovirus infection after transplantation. Transplant Proc. 1994;26(5 Suppl 1):7–11.

    CAS  PubMed  Google Scholar 

  18. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med. 1998;338(24):1741–51.

    Article  CAS  PubMed  Google Scholar 

  19. Holt C, Winston D. Transplantation of the liver. 2nd ed. Philadelphia: Elsevier; 2005.

    Google Scholar 

  20. Munksgaar B. Epstein-Barr virus and lymphoproliferative disorders after transplantation. Am J Transplant. 2004;4(Suppl. 10):59–65.

    Google Scholar 

  21. Cockfield SM. Identifying the patient at risk for post-transplant lymphoproliferative disease. Transpl Infect Dis. 2001;3:70–8.

    Article  CAS  PubMed  Google Scholar 

  22. Loren AW, Tsai DE. Post-transplant lymphoproliferative disorder. Clin Chest Med. 2005;26(4):631–45.

    Article  PubMed  Google Scholar 

  23. Tiede C, Maecker-Kolhoff B, Klein C, Kreipe H, Hussein K. Risk factors and prognosis in T-cell posttransplantation lymphoproliferative diseases: reevaluation of 163 cases. Transplantation. 2013;95(3):479–88.

    Article  CAS  PubMed  Google Scholar 

  24. Hsi ED, Picken MM, Alkan S. Post-transplantation lymphoproliferative disorder of the NK-cell type: a case report and review of the literature. Mod Pathol. 1998;11(5):479–84.

    CAS  PubMed  Google Scholar 

  25. Schober T, Framke T, Kreipke H. Characteristics of early and late PTLD development in pediatric solid organ transplant recipients. Transplantation. 2013;95(1):240–6.

    Article  PubMed  Google Scholar 

  26. Wistinghausen B, Gross TG, Bollard C. Post-transplant lymphoproliferative disease in pediatric solid organ transplant recipients. Pediatr Hematol Oncol. 2013;30(6):520–31.

    Article  CAS  PubMed  Google Scholar 

  27. Pinho-Apezzato ML, Tannuri U, Tannuri AC. Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience. Transplant Proc. 2010;42(5):1763–8.

    Article  CAS  PubMed  Google Scholar 

  28. Gross TG, Savoldo B, Punnett A. Posttransplant lymphoproliferative diseases. Pediatr Clin N Am. 2010;57(2):481–503.

    Article  Google Scholar 

  29. Haque T, Wilkie GM, Jones MM. Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial. Blood. 2007;110(4):1123–31.

    Article  CAS  PubMed  Google Scholar 

  30. Pinto M, Dobson S. BK and JC virus: a review. J Infect. 2014;68(Suppl 1):S2–8.

    Article  PubMed  Google Scholar 

  31. Sandler ES, Aquino VM, Goss-Shohet E, Hinrichs S, Krisher K. BK papova virus pneumonia following hematopoietic stem cell transplantation. Bone Marrow Transpl. 1997;20(2):163–5.

    Google Scholar 

  32. Englund JE, Whimbey EE. Community-acquired respiratory viruses after hematopoietic stem cell or solid organ transplantation. Transplant infections. 1st ed. Baltimore: Lippincott Williams & Wilkins; 2003.

    Google Scholar 

  33. Kumar D, Morris MI, Kotton CN, Fischer SA, Michaels MG, Allen U, et al. Guidance on novel influenza A/H1N1 in solid organ transplant recipients. Am J Transplant. 2010;10(1):18–25.

    Article  CAS  PubMed  Google Scholar 

  34. Michaels MG, Fonseca-Aten M, Green M, Charsha-May D, Friedman B, Seikaly M, et al. Respiratory syncytial virus prophylaxis: a survey of pediatric solid organ transplant centers. Pediatr Transplant. 2009;13(4):451–6.

    Article  PubMed  Google Scholar 

  35. Bhadri VA, Lee-Horn L, Shaw PJ. Safety and tolerability of cidofovir in high-risk pediatric patients. Transpl Infect Dis. 2009;11(4):373–9.

    Article  CAS  PubMed  Google Scholar 

  36. American Society of Transplantation Infectious Diseases Community of Practice. Mycobacterium tuberculosis. Am J Transplant. 2004;10:37–41.

    Google Scholar 

  37. Catherinot E, Lanternier F, Bougnoux ME. Pneumocystis jirovecii pneumonia. Infect Dis Clin N Am. 2010;24(1):107–38.

    Article  Google Scholar 

  38. Kimberlin DW, Brady MT, Jackson MA, Long SS, editors. Red Book. 2015 report of the Committee on Infectious Diseases. 30th ed. Elk Grove Village: American Academy of Pediatrics; 2015.

    Google Scholar 

  39. Michaels MG, Wald ER, Fricker FJ, del Nido PJ, Armitage J. Toxoplasmosis in pediatric recipients of heart transplants. Clin Infect Dis. 1992;14(4):847–51.

    Article  CAS  PubMed  Google Scholar 

  40. Feagans J, Victor D, Moehlman M, Florman SS, Regenstein F, Balart LA, et al. Interstitial pneumonitis in the transplant patient: consider sirolimus-associated pulmonary toxicity. J La State Med Soc. 2009;161(3):166. 168–72

    PubMed  Google Scholar 

  41. Garrod AS, Goyal RK, Weiner DJ. Sirolimus-induced interstitial lung disease following pediatric stem cell transplantation. Pediatr Transplant. 2015;19(3):E75–7.

    Article  CAS  PubMed  Google Scholar 

  42. Das BB, Shoemaker L, Subramanian S, Johnsrude C, Recto M, Austin EH. Acute sirolimus pulmonary toxicity in an infant heart transplant recipient: case report and literature review. J Heart Lung Transplant. 2007;26(3):296–8.

    Article  PubMed  Google Scholar 

  43. Cuhna BA, Syed U, Mickail N. Renal transplant with bronchiolitis obliterans organizing pneumonia (BOOP) attributable to tacrolimus and herpes simplex virus (HSV) pneumonia. Heart Lung. 2012;41(3):310–5.

    Article  Google Scholar 

  44. Otton J, Hayward CS, Keogh AM, Glanville AR, MacDonald PS. Everolimus-associated pneumonitis in 3 heart transplant recipients. J Heart Lung Transplant. 2009;28(1):104–6.

    Article  PubMed  Google Scholar 

  45. Depuydt P, Nollet J, Benoit D. Fatal acute pulmonary injury associated with everolimus. Ann Pharmacother. 2012;46(3):e7.

    Article  PubMed  Google Scholar 

  46. Gross DC, Sasaki TM, Buick MK, Light JA. Acute respiratory failure and pulmonary fibrosis secondary to administration of mycophenolate mofetil. Transplantation. 1997;64(11):1607–9.

    Article  CAS  PubMed  Google Scholar 

  47. Gorgan M, Bockorny B, Lawlor M, Volpe J, Fiel-Gan M. Pulmonary hemorrhage with capillaritis secondary to mycophenolate mofetil in a heart-transplant patient. Arch Pathol Lab Med. 2013;137(11):1684–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Geoffrey Kurland M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Szentpetery, S., Weiner, D.J., Kurland, G. (2018). Pulmonary Complications of Solid Organ Transplantation. In: Koumbourlis, A., Nevin, M. (eds) Pulmonary Complications of Non-Pulmonary Pediatric Disorders. Respiratory Medicine. Humana Press, Cham. https://doi.org/10.1007/978-3-319-69620-1_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-69620-1_16

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-69619-5

  • Online ISBN: 978-3-319-69620-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics